COMBIKIT OF PIOGLITAZONE AND METFORMIN TAB
COMBIKIT OF PIOGLITAZONE AND METFORMIN TAB: COMBIKIT OF PIOGLITAZONE AND METFORMIN TAB is a combination medication that contains two active ingredients: pioglitazone and metformin. It is used in the treatment of type 2 diabetes mellitus to help control blood sugar levels.
Pioglitazone is classified as a thiazolidinedione and acts by improving insulin sensitivity in the body. It helps the cells respond better to insulin, which leads to better utilization of glucose and reduced production of glucose by the liver.
Metformin, on the other hand, is a biguanide that works by decreasing glucose production in the liver and reducing the absorption of glucose from the intestines. It also improves insulin sensitivity and increases the uptake and use of glucose by peripheral tissues.
The combination of pioglitazone and metformin provides complementary effects, resulting in better glycemic control than using each medication alone.
The typical starting dose of COMBIKIT OF PIOGLITAZONE AND METFORMIN TAB is one tablet once or twice daily, depending on the individual’s response and needs. The dose can be adjusted by a healthcare professional based on blood sugar levels and other factors. It is usually taken with meals to reduce gastrointestinal side effects.
Common side effects of this medication may include weight gain, edema (swelling), headache, dizziness, blurred vision, muscle pain, back pain, and upper respiratory tract infection. Additionally, metformin may cause gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal discomfort. It is important to consult a healthcare professional if these side effects persist or worsen.
Rare but serious side effects associated with pioglitazone include liver problems, heart failure, and an increased risk of bladder cancer. Regular monitoring of liver function and cardiovascular status is essential during treatment with this medication.
It is important to note that COMBIKIT OF PIOGLITAZONE AND METFORMIN TAB should not be used in individuals with severe kidney or liver disease, heart failure, or those at risk for bladder cancer. It is always recommended to consult a healthcare professional before starting or adjusting any medication regimen.
